Lonza plans to establish centers of excellence for cell and gene therapy. Lonza’s Cell- and Gene-Therapy Centers of Excellence will include Lonza sites that are already functioning.

The company says the Lonza sites in Pearland, Texas and Geleen/Maastricht, the Netherlands will offer a fully integrated range of cell- and gene-therapy services, including process and analytical development, clinical-product supply, and commercial-product supply. Lonza says its sites in Portsmouth, New Hampshire and Singapore will serve both as clinical and commercial manufacturing sites.

Lonza says the focus on cell- and gene-therapy centers of excellence will shift Lonza’s cell-therapy operations out of Walkersville, Maryland and enable the Walkersville site to focus entirely on the company’s Bioscience Solutions business.

Source: Lonza